Patent-pending · In development
A localized approach to comfort in absorbent hygiene.
FCIZ™ is a patent-pending technology platform being developed to introduce a localized functional comfort zone within an absorbent product, with the objective of preserving acceptable absorbency, rewet, fluid-transfer, and dryness performance.
The opportunity
Where comfort is decided.
Prolonged contact
Absorbent products are often worn for extended periods, making the wearer-facing interface central to the experience.
Friction and movement
Everyday movement introduces surface friction that can influence perceived comfort over a long wear period.
Moisture and skin comfort
Sustained moisture exposure and skin comfort are common considerations across absorbent hygiene use.
Differentiation without disruption
Brands need meaningful product differentiation that can be evaluated against established manufacturing infrastructure.
High-level concept
A strategically positioned wearer-facing zone.
FCIZ is being evaluated as a localized functional zone positioned at the wearer-facing surface of an absorbent product, rather than a redesign of the product as a whole. The intent is to address the interface where comfort is experienced while allowing fluid to move into the absorbent structure beneath it.
Formulations, ingredient ratios, dimensions, layer specifications, suppliers, process settings, and engineering detail are not disclosed publicly.
- Wearer-facing layer
- Localized functional comfort zone
- Downward fluid movement
- Absorbent structure
Performance under evaluation
Development objectives
What we intend to achieve.
These are development objectives under evaluation. They are not statements of demonstrated performance.
- 01Improve perceived comfort at the wearer interface
- 02Evaluate friction-related comfort during wear
- 03Preserve acceptable absorbency, rewet, and dryness performance
- 04Support premium product differentiation
- 05Explore integration with established product architectures
Initial application
Menstrual care.
Menstrual pads are the first application under development, where prolonged wear makes the wearer interface especially important. Early prototypes have been produced and candidate configurations are under evaluation.
Follow development →Broader potential
Adjacent absorbent categories.
Adult incontinence, postpartum care, and other absorbent-care categories are potential future areas. Each would require category-specific development, testing, regulatory review, and claims support before any application.
Development status · August 2026
Where the work stands.
Early menstrual-pad prototypes have been produced and candidate configurations are under evaluation. Final product specifications and validated performance claims have not yet been established.
Prototype evaluation
Candidate prototype configurations are being compared for internal evaluation.
Material and formulation evaluation
Candidate materials are being screened against comfort and performance objectives.
Manufacturing feasibility
Compatibility with established converting approaches is being assessed.
Friction and comfort testing
Bench-level friction and comfort assessment is planned and underway at prototype stage.
Absorption, rewet and dryness
Core performance evaluation is being defined alongside stability considerations.
Independent validation planning
Third-party laboratory validation is being scoped for later development phases.
No therapeutic or clinical-performance claims are being made at this stage.
Intellectual property
Protected, and shared carefully.
Patent applications relating to FCIZ have been filed in the United States and internationally.
Technical detail is shared selectively with qualified parties under confidentiality arrangements. Public materials are intentionally non-confidential.
Partnership opportunities
Who we would like to hear from.
Absorbent-hygiene manufacturers and brands
Start a conversationOEM and converting partners
Start a conversationNonwoven and material suppliers
Start a conversationIndependent laboratories
Start a conversationMenstrual-care and women's-health researchers and clinicians
Start a conversationLicensing and strategic commercialization partners
Start a conversation
FCIZ is under development. It is not currently offered for sale, and nothing on this page constitutes a product claim or an offer of commercial availability.